Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.  CME information and select publications <a href="https://www.researchtopractice.com/GMO25" rel="noopener noreferrer" target="_blank">here</a>.

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. CME information and select publications here.

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. &nbsp;CME information and select publications <a href="https://www.researchtopractice.com/GMO25" rel="noopener noreferrer">here</a>.

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Share HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Sign up to save your podcasts

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

More shows like Breast Cancer Update

Gastrointestinal Cancer Update

Lung Cancer Update

Prostate Cancer Update

The People's Pharmacy

Gynecologic Oncology Update

Hematologic Oncology Update

Dermatologic Oncology Update

Research To Practice | Oncology Videos

FoundMyFitness

JAMA Clinical Reviews

Hidden Brain

The ONS Podcast

Dhru Purohit Show

The Peter Attia Drive

Oncology Today with Dr Neil Love

Huberman Lab

ZOE Science & Nutrition

Two Onc Docs